Impact of COVID-19 on neurological patients attending a botulinum toxin service

被引：13

作者：

Erro, Roberto ^{[1
]}

Scannapieco, Sara ^{[1
]}

Russo, Maria ^{[1
]}

Picillo, Marina ^{[1
]}

Barone, Paolo ^{[1
]}

机构：

[1] Univ Salerno, Dept Med Surg & Dent, Scuola Med Salernitana, Via Allende, Baronissi, SA, Italy

来源：

NEUROLOGICAL SCIENCES | 2021年 / 42卷 / 02期

关键词：

D O I：

10.1007/s10072-020-04940-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：433 / 435

页数：3

共 5 条

[1] Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus Hotspot [J].

Ali, Ashhar .

HEADACHE, 2020, 60 (06) :1183-1186

[2] Botulinumtoxin type A therapy for cervical dystonia [J].

Castelao, Mafalda ;

Marques, Raquel E. ;

Duarte, Goncalo S. ;

Rodrigues, Filipe B. ;

Ferreira, Joaquim ;

Sampaio, Cristina ;

Moore, Austen P. ;

Costa, Joao .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (12)

[3] Botulinum toxin drugs: brief history and outlook [J].

Dressler, D. .

JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (03) :277-279

[4] Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort [J].

Dressler, Dirk ;

Adib Saberi, Fereshte .

JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (09) :1271-1274

[5] Telemedicine in Movement Disorders: Lecons du Coronavirus Disease 2019 [J].

Mulroy, Eoin ;

Menozzi, Elisa ;

Lees, Andrew J. ;

Lynch, Timothy ;

Lang, Anthony E. ;

Bhatia, Kailash P. .

MOVEMENT DISORDERS, 2020, 35 (11) :1893-1896

← 1 →